Cargando…

Prevalence and Patient Outcomes of Adult Primary Hypercholesterolemia and Dyslipidemia in the UK: Longitudinal Retrospective Study Using a Primary Care Dataset from 2009 to 2019

BACKGROUND: Guidelines for the management of dyslipidemias recommend intensive low-density lipoprotein (LDL-C) control through lifestyle advice and lipid-lowering drugs to reduce the risk of cardiovascular disease (CVD). OBJECTIVE: This retrospective study aimed to characterize the adult primary car...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bilitou, Aikaterini, Were, John, Farrer, Archie, Rabe, Adrian, Ming, Simon Wan Yau, Haq, Inaam, Dunton, Kyle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994561/ https://www.ncbi.nlm.nih.gov/pubmed/35411162 http://dx.doi.org/10.2147/CEOR.S347085

Ejemplares similares

Pitavastatin approved for treatment of primary hypercholesterolemia and combined dyslipidemia
por: Sasaki, Jun
Publicado: (2010)

The Draupadi of dyslipidemia: Familial hypercholesterolemia
por: Kalra, Sanjay, et al.
Publicado: (2016)

Safety and efficacy of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia
por: Viljoen, Adie, et al.
Publicado: (2010)

Critical appraisal of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia
por: Hussein, Ayman A, et al.
Publicado: (2010)

Review of extended-release niacin/laropiprant fixed combination in the treatment of mixed dyslipidemia and primary hypercholesterolemia
por: Parhofer, Klaus G
Publicado: (2009)

Burden and impact of chronic cough in UK primary care: a dataset analysis
por: Hull, James H, et al.
Publicado: (2021)

Efficacy and Safety of Evolocumab in Chinese Patients with Primary Hypercholesterolemia and Mixed Dyslipidemia: 12-Week Primary Results of the HUA TUO 华佗 Randomized Clinical Trial
por: Tan, Hong, et al.
Publicado: (2023)

Vaccine targeting ANGPTL3 ameliorates dyslipidemia and associated diseases in mouse models of obese dyslipidemia and familial hypercholesterolemia
por: Fukami, Hirotaka, et al.
Publicado: (2021)

Prevalence of dyslipidemia and hypercholesterolemia awareness: results from the Lookup 7+ online project
por: Martone, Anna Maria, et al.
Publicado: (2022)

Infective endocarditis in dogs in the UK: 77 cases (2009‐2019)
por: Berrezaie, M., et al.
Publicado: (2022)

Extended Release Niacin-Laropiprant in Patients with Hypercholesterolemia or Mixed Dyslipidemias Improves Clinical Parameters
por: Vosper, Helen
Publicado: (2011)

Successful Genetic Screening and Creating Awareness of Familial Hypercholesterolemia and Other Heritable Dyslipidemias in the Netherlands
por: Zuurbier, Linda C., et al.
Publicado: (2021)

The economic impact of hypercholesterolemia and mixed dyslipidemia: A systematic review of cost of illness studies
por: Ferrara, Pietro, et al.
Publicado: (2021)

Angiopoietin-like proteins inhibitors: New horizons in the treatment of atherogenic dyslipidemia and familial hypercholesterolemia
por: Surma, Stanisław, et al.
Publicado: (2023)

The red blood cell as a mediator of endothelial dysfunction in patients with familial hypercholesterolemia and dyslipidemia
por: Mahdi, Ali, et al.
Publicado: (2022)

Mixed dyslipidemias in primary care patients in France
por: Laforest, Laurent, et al.
Publicado: (2012)

Antiplatelet Effects of PCSK9 Inhibitors in Primary Hypercholesterolemia
por: Pęczek, Piotr, et al.
Publicado: (2021)

Mapping of familial hypercholesterolemia and dyslipidemias basic management infrastructure in Pakistan: a cross-sectional study
por: Sadiq, Fouzia, et al.
Publicado: (2023)

PCSK9 Gene Participates in the Development of Primary Dyslipidemias
por: Matías-Pérez, D, et al.
Publicado: (2021)

Factors of Compliance in Patients with Hypercholesterolemia Using Rosuvastatin in Primary Care
por: Kim, Hye Young, et al.
Publicado: (2012)

Primary coronary artery pseudoaneurysm in a patient with familial hypercholesterolemia
por: Fujiyoshi, Toshiki, et al.
Publicado: (2019)

QTLMAS 2009: simulated dataset
por: Coster, Albart, et al.
Publicado: (2010)

Trends in Primary Antibiotic Resistance in H. pylori Strains Isolated in Italy between 2009 and 2019
por: Saracino, Ilaria Maria, et al.
Publicado: (2020)

Kidney Function and Estimated Vascular Risk in Patients with Primary Dyslipidemia
por: Tziomalos, Konstantinos, et al.
Publicado: (2009)

APOE Molecular Spectrum in a French Cohort with Primary Dyslipidemia
por: Abou Khalil, Yara, et al.
Publicado: (2022)

Severe Dyslipidemia Mimicking Familial Hypercholesterolemia Induced by High-Fat, Low-Carbohydrate Diets: A Critical Review
por: Houttu, Veera, et al.
Publicado: (2023)

Simulation study on LDL cholesterol target attainment, treatment costs, and ASCVD events with bempedoic acid in patients at high and very-high cardiovascular risk
por: Katzmann, Julius L., et al.
Publicado: (2022)

Patterns and trends in eczema management in UK primary care (2009–2018): A population‐based cohort study
por: de Lusignan, Simon, et al.
Publicado: (2020)

Search for genetic factors predisposing to atherogenic dyslipidemia
por: Yip, Agustin G, et al.
Publicado: (2003)

Efficacy and Tolerability of a Fixed-Dose Combination of Rosuvastatin and Ezetimibe Compared with a Fixed-Dose Combination of Simvastatin and Ezetimibe in Brazilian Patients with Primary Hypercholesterolemia or Mixed Dyslipidemia: A Multicenter, Randomized Trial
por: Vattimo, Antonio Carlos Amedeo, et al.
Publicado: (2020)

Lower‐Intensity Statins Contributing to Gaps in Care for Patients With Primary Severe Hypercholesterolemia
por: Eid, Wael E., et al.
Publicado: (2021)

Case Series of Genetically Confirmed Index Cases of Familial Hypercholesterolemia in Primary Care
por: Kamal, Aisyah, et al.
Publicado: (2023)

Primary Barriers of Adherence to a Structured Nutritional Intervention in Patients with Dyslipidemia
por: Del Razo-Olvera, Fabiola Mabel, et al.
Publicado: (2021)

Dyslipidemia management for primary prevention of cardiovascular events: Best in-clinic practices
por: Thongtang, Nuntakorn, et al.
Publicado: (2022)

Prospective Registry Study of Primary Dyslipidemia (PROLIPID): Rationale and Study Design
por: Tada, Hayato, et al.
Publicado: (2022)

Association between sleep insufficiency and dyslipidemia: a cross-sectional study among Greek adults in the primary care setting
por: Tsiptsios, Dimitrios, et al.
Publicado: (2022)

Synergistic Effects of Inflammation and Atherogenic Dyslipidemia on Subclinical Carotid Atherosclerosis Assessed by Ultrasound in Patients with Familial Hypercholesterolemia and Their Family Members
por: Lin, Po-Chih, et al.
Publicado: (2022)

Socioeconomic variations in access to smoking cessation interventions in UK primary care: insights using the Mosaic classification in a large dataset of primary care records
por: Douglas, Laura, et al.
Publicado: (2013)

Concordance in the recording of stroke across UK primary and secondary care datasets: a population-based cohort study
por: Morgan, Ann, et al.
Publicado: (2021)

Prevalence of Dyslipidemia and Management in the Thai Population, National Health Examination Survey IV, 2009
por: Aekplakorn, Wichai, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_83qsgmuv5ulbp7effmbghu1mgs